Four monoclonal anti-parathyroid antibodies were generated after immunization of mice with intact cells from human parathyroid tissue. All four monoclonal antibodies reacted in immunohistochemistry with structures present on parathyroid epithelial cells and proximal-tubule cells of the kidney but were unreactive with all other human tissues investigated. Immunofluorescence microscopy on suspended human parathyroid cells showed that the antibodies reacted with structures present on the cell surface. Two of these antibodies efficiently blocked the increase in cytoplasmic calcium concentration of parathyroid cells that is normally associated with increased concentrations of extracellular calcium. The results indicate that these two antibodies interfere with a calcium-sensing mechanism of parathyroid cells-i.e., a potential calcium receptor by which extracellular calcium regulates cytoplasmic calcium and hormone release in these cells.
human lymphoid cells, for example, it has been possible to define a number of receptor molecules involved in the communication between lymphocytes and their environment (for reviews see refs. 2 and 3).
The search for unique cell surface receptors with monoclonal antibodies has only to a limited extent been applied to the study of endocrine cells (4) , although these cells may in many respects be good candidates for this methodology. Endocrine cells can be expected to express a limited number of unique cell surface structures, because they normally respond to a limited set of external stimuli. In addition, endocrine cells are sometimes difficult to obtain in sufficient amounts to permit the isolation and characterization of cell surface receptors by means of conventional biochemical methods.
We describe in this paper the generation of monoclonal antibodies to parathyroid endocrine cells, using a new and efficient protocol for hybridoma production (5) combined with immunohistochemical screening for antibody specificity.
MATERIALS AND METHODS
Tissue Samples. Samples were obtained from human parathyroid glands that were inadvertently removed at thyroid operations or from patients operated on for hyperparathyroidism. Other human tissue pieces were taken from organs removed at surgery or from organs used for transplantation purposes. Tissue biopsy specimens were also obtained from a monkey (Cynomolgus) and from rats (Lewis strain). Biopsy specimens and tissue pieces were immediately placed in ice-cold Histocon (Histo-Lab; Bethlehem Trading Ltd., Goteborg, Sweden) and subsequently quick-frozen in -70TC isopentane.
Parathyroid Cell Dispersion. Dispersed parathyroid cells were obtained from biopsy samples of normal parathyroid glands and from parathyroid adenomas by collagenase treatment and Percoll purification as described (6) . Some of the cells were used for immediate experiments ([Ca2+]i studies, see below), whereas some were kept cryopreserved in liquid nitrogen without loss of viability.
Immunization and Production of Hybridomas. Thawed, dispersed human parathyroid adenoma cells (106 cells in 100 ,ul) were mixed with an equal volume of Freund's complete adjuvant (Difco) and used to immunize each of five male DBA/1 mice in the foot pads (breeding pairs of DBA/1 mice were originally obtained from The Jackson Laboratory). Following a recently described protocol for hybridoma production (5), we removed popliteal and inguinal lymph node cells 9 days after immunization and fused them with mouse myeloma cells (P3X63-Ag8.653). After fusion, hybridomas were incubated in hypoxanthine/aminopterin/thymidinecontaining medium (7) in microwell plates, which were later screened for growing hybridomas by phase-contrast microscopy. The hybridomas selected by the immunohistochemical screening procedure were subcloned twice by limiting dilution (0.5 cell per well), and the resulting subclones were screened anew by immunohistochemistry.
Immunohistochemical and Immunofluorescence Techniques. Immunohistochemical staining was performed on acetone-fixed, 6-,um-thick frozen sections of the various tissues, using a mouse peroxidase-antiperoxidase technique (8) . Primary antibodies were either hybridoma supernatants (diluted 1:5) or purified monoclonal antibodies (1-5 pug/ml). Monoclonal anti-HLA-DR antibodies (9) (Becton Dickinson) were used as positive controls, and monoclonal antibodies to collagen type II (10) were used as negative controls.
Immunofluorescence staining was performed on viable dispersed parathyroid adenoma cells and on leukocytes from healthy individuals, obtained by means of centrifugation of peripheral blood on Ficoll-Isopaque gradients (11) . Primary antibodies were either the purified anti-parathyroid monoclonal antibodies, the anti-Leu-4 antibody to human T-cell receptors (12) (16, 17) and with a Kd for the Ca2+-fura-2 complex of 231 nM. Purified IgG fractions of the respective antibodies were dialyzed extensively against 25 mM Hepes, pH 7.4/125 mM NaCl/5.9 mM KCl/0.5 mM MgCl2/0.5 mM CaCl2 before being added to the parathyroid cells; the concentration of added antibodies was always >10 times the final antibody concentration in the test system. None of the antibodies affected viability of the cells as measured by the trypan blue exclusion test.
RESULTS
Production and Screening of Antibodies. Immunization with dispersed human parathyroid adenoma cells and subsequent fusion using regional lymph node cells resulted in 88 growing hybridoma cultures from which supernatants were removed and tested for reactivity with frozen sections of human parathyroid glands. Nineteen of these supernatants reacted with cells of the human parathyroid glands (Table 1) . Five supernatants reacted with stroma cells, and 14 with parathyroid parenchymal cells. Twelve of these 14 supernatants outlined the surface of the parenchymal cells, whereas 2 showed an even staining of these cells, suggesting the recognition of cytoplasmic structures.
All supernatants that reacted with parathyroid cells were then tested for reactivity with frozen sections from a normal human thyroid gland and from normal human lymph node. The two supernatants that showed a cytoplasmic staining pattern, as well as eight of the supernatants that gave a surface staining pattern on parathyroid parenchymal cells, reacted also with corresponding structures on thyroid follicular cells. In contrast, the four remaining antibodies that reacted with surface structures of the parathyroid cells showed no reactivity with thyroid or lymph node cells ( Table  2) .
The hybridomas corresponding to these latter four "parathyroid-specific" supernatants were subsequently subjected to subcloning and tested again by immunohistochemistry on parathyroid, thyroid, and lymph node tissue sections. All subclones showed the same reactivity as the original super- Reactivity was assessed by immunohistochemistry on supernatants from the 88 growing hybridomas originally obtained from cells spread in 500 wells. The reactivity pattern is shown for those hybridoma supernatants that reacted with parathyroid tissue in the first screening test. Reactivity with parathyroid tissue is designated (s) for antibodies staining cell surfaces and (i) for antibodies giving a cytoplasmic staining. Group A includes those antibodies that reacted with parenchymal parathyroid cells, and group B includes antibodies that reacted with cells in the stroma of the parathyroid gland.
natants, and one subclone from each of the original four hybridoma cultures was expanded for further large-scale antibody production in vitro.
Reactivity of the Parathyroid-Reactive Antibodies with Other Tissues. Supernatants from the four selected parathyroidreactive hybridoma subclones were tested for reactivity with Table 2 . Specificities and isotypes of monoclonal antibodies that were specific for parathyroid cells in the primary screening (see Table 1 ) Reactivity All four antibodies were negative for the following tissues. Normal human tissues: thyroid, thymus, lymph node, spleen, lung, liver, skin, skeletal muscle, pancreas, intestine (small bowel and colon), parotid gland, adrenal gland, bone, mammary gland,and prostate. Human tumors: medullary thyroid carcinoma, insulinoma, mid-gut carcinoid, pheochromocytoma, and Conn tumor. Normal monkey tissues: thyroid, thymus, lymph node, spleen, ovary, liver, salivary gland, and small intestine. Normal rat tissues: thyroid, thymus, lymph node, lung, heart muscle, cerebral cortex, hypothalamus, pancreas, stomach, duodenum, salivary gland, liver, and spleen.
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frozen sections from a large number of human and animal tissues. As seen from Table 2 , the antibodies showed almost identical patterns of reactivity-they reacted with glandular cells in the parathyroid (Fig. 1) and with epithelial cells in the tubules of the kidney (Fig. 2) but were completely negative for all other tissues that were tested. The staining of the kidney tubule cells was restricted to the epithelial cells of the proximal tubules, and the strongest staining was seen on the surface of the brush border outlining the tubules (Fig. 2) be provided in a forthcoming paper). Two of the four antibodies reacted both with parathyroid and with kidney tubule cells of the monkey, and one reacted with the two corresponding structures of the rat ( Table 2 ). The anti-HLA-DR antibodies reacted with dendritic-like cells in the respective tissues according to earlier described patterns (18) , whereas no reactivity was seen with the monoclonal anticollagen antibodies. Immunofluorescence Studies. In order to investigate whether the structure(s) recognized by the monoclonal antibodies were present on the outer surface of the parathyroid cells, dispersed normal human parathyroid cells, as well as human peripheral leukocytes, were subjected to immunofluorescence staining with the four anti-parathyroid antibodies and relevant control antibodies. All four anti-parathyroid antibodies gave rise to a brilliant staining of the surface of the parathyroid epithelial cells (Fig. 3) (Fig. 4) The nature and function(s) of the cell surface structures recognized by the antibodies remain to be explored; this issue will be discussed in more detail elsewhere, on the basis of more extensive functional studies that have been carried out in collaboration with E. Gylfe at the department of Medical Cell Biology, Uppsala. The preliminary studies reported herein suggest, however, that at least two of the antiparathyroid antibodies recognize molecules involved in a calcium-sensing mechanism of the parathyroid cells-i.e., a calcium receptor, which has been postulated for these cells (15) . As neither the third IgG anti-parathyroid antibody (Eli) nor the irrelevant monoclonal IgGs caused any similar effects, it is unlikely that the observed phenomenon is nonspecific. Instead, we speculate that the B6 and G11 antibodies on one hand, and the Eli antibody on the other hand, recognize different epitopes on a molecule or molecular complex involved in calcium sensing. If so, these monoclonal antibodies should provide powerful tools for further characterization of the nature of the putative calcium-sensing structures on parathyroid epithelial cells and permit investigations on whether similar calcium-sensing structures are present also on proximal-tubule cells of the kidney. The fact that some of the antibodies show cross-species reactivity with kidney and parathyroid cells of monkeys and rats will also make in vivo experiments with the antibodies feasible.
